Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, United States.
Biochem Biophys Res Commun. 2013 Sep 6;438(4):660-5. doi: 10.1016/j.bbrc.2013.07.125. Epub 2013 Aug 7.
The present study was conducted to determine whether fetuin-A, a dominant serum protein plays a role in chemo-attraction and chemo-invasion of carcinoma cells in vitro. Serum is normally used as positive chemotaxis control in Boyden chamber motility assays, prompting the need to identify the factor/s in serum that contributes the bulk of chemo-taxis and invasion. Serum has a plethora of chemotactic factors including stromal derived factor 1 also known as CXCL12. Using highly purified fetuin-A, we compared its chemo-attraction potential to culture medium containing 10% fetal bovine serum. We also investigated its ability to attract tumor cells through a bed of Matrigel (invasion assay). We demonstrated, using similar concentration range of fetuin-A found in blood, that it robustly supports both directed chemo-attraction and invasion of breast tumor cells. More importantly, we showed that at low concentrations (fetuin-A coated wells) itinteracts synergistically with CXCL12 to promote chemotaxis. The presence of plasminogen (PL) blunted the fetuin-A mediated chemotaxis. Taken together, the data suggest an in vivo chemotaxis/invasion role for fetuin-A.
本研究旨在确定胎球蛋白 A(一种主要的血清蛋白)是否在体外参与癌细胞的趋化和侵袭。在 Boyden 室迁移试验中,血清通常用作阳性趋化控制,这促使我们需要鉴定血清中促进趋化和侵袭的因子。血清中有大量趋化因子,包括基质衍生因子 1(也称为 CXCL12)。我们使用高度纯化的胎球蛋白 A,将其趋化潜力与含有 10%胎牛血清的培养基进行了比较。我们还研究了它通过 Matrigel 床(侵袭试验)吸引肿瘤细胞的能力。我们证明,在血液中发现的类似浓度范围内的胎球蛋白 A 能够强烈支持乳腺癌细胞的定向趋化和侵袭。更重要的是,我们表明,在低浓度(胎球蛋白 A 包被的孔)下,它与 CXCL12 协同作用促进趋化。纤溶酶原(PL)的存在削弱了胎球蛋白 A 介导的趋化作用。综上所述,这些数据表明胎球蛋白 A 在体内具有趋化和侵袭作用。